Alcohol abuse in an elderly woman taking donepezil for Alzheimer disease [12]

Journal of Clinical Psychopharmacology

Volumn 26, Issue 6, 2006, Pages 683-685

  Marinho, Valeska ^a   Laks, Jerson ^a   Engelhardt, Eliasz ^a   Conn, David ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL;

AGED; ALCOHOL ABUSE; ALCOHOLISM; ALZHEIMER DISEASE; ANAMNESIS; BEHAVIOR DISORDER; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; IMPULSIVENESS; IRRITABILITY; LABORATORY TEST; LETTER; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SIDE EFFECT;

AGED, 80 AND OVER; ALCOHOL DRINKING; ALCOHOLISM; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; COMPULSIVE BEHAVIOR; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; INDANS; NOOTROPIC AGENTS; PIPERIDINES;

EID: 33751103683     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000246213.41647.9f     Document Type: Letter

References (20)

1. Inglis F. The tolerability and safety of cholinesterase inhibitors in the treatment of dementia. Int J Clin Pract Suppl. 2002;127:S45-S63.
2. Passmore AP, Bayer AJ, Steinhagen-Thiessen E. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials. J Neurol Sci. 2005;15:229-230, 141-146.
3. Roth M, Tym E, Mountjoy CG, et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry. 1986;149:698-709.
4. Folstein MF, Folstein SE, Mc Hugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
5. Engelhardt E, Laks J, Cavalcanti JLS, et al. Alzheimer's disease, limbic 1H-MRS and CDR stages. J Neurol Sci. 2003;214:63.
6. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308-2314.
7. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179-186.
8. Ganzini L, Atkinson RM. Substance abuse. In: Sadavoy J, Lazarus LW, Jarvic LF, Grossberg GT, eds. Comprehensive Review of Geriatric Psychiatry-II. London, United Kingdom: American Psychiatric Press Inc; 1996:659-692.
9. Kamarajan C, Porjesz B, Jones Ka, et al. Alcoholism is a disinhibitory disorder: neurophysiological evidence from a Go/No-Go task. Biol Psychol. 2005;69(3):353-373.
10. Lynch T, Sano M, Marder KS, et al. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology. 1994;44(10):1878-1884.
11. Muller-Thomsen T, Haasen C. Alcohol consumption in Alzheimer's disease. A case report. Eur Addict Res. 2003;9(1):51-52.
12. Bohnen NI, Kaufer DI, Hendrickson R, et al. Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005;76(3):315-319.
13. Mega MS, Dinov ID, Porter V, et al. Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study. Arch Neurol. 2005;62(5):721-728.
14. Iga JI, Araki M, Ishimoto Y, et al. A case of Korsakoff's syndrome improved by high doses of donepezil. Alcohol Alcohol. 2001;36(6):553-555.
15. Gibson RC, Barnaby L. Rivastigmine in the treatment of alcohol-induced persisting dementia. West Indian Med J. 2003;52(1):59-61.
16. Kim KY, Ke V, Adkins LM. Donepezil for alcohol-related dementia: a case report. Pharmacotherapy. 2004;24(3):419-421.
17. Driver-Dunckley E, Samanta J, Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology. 2003;61(3):422-423.
18. Gschwandtner U, Aston J, Renaud S, et al. Pathologic gambling in patients with Parkinson's disease. Clin Neuropharmacol. 2001;24(3):170-172.
19. Bergh C, Eklund T, Sodersten P, et al. Altered dopamine function in pathological gambling. Psychol Med. 1997;27(2):473-475.
20. Zhang L, Zhou FM, Dani JA. Cholinergic drugs for Alzheimer's disease enhance in vitro dopamine release. Mol Pharmacol. 2004;66(3):538-544.